Cargando…

Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-D

Vascular endothelial growth factor (VEGF) C and VEGF-D stimulate lymphangiogenesis and angiogenesis in tissues and tumors by activating the endothelial cell surface receptor tyrosine kinases VEGF receptor (VEGFR) 2 and VEGFR-3. These growth factors are secreted as full-length inactive forms consisti...

Descripción completa

Detalles Bibliográficos
Autores principales:	McColl, Bradley K., Baldwin, Megan E., Roufail, Sally, Freeman, Craig, Moritz, Robert L., Simpson, Richard J., Alitalo, Kari, Stacker, Steven A., Achen, Marc G.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2003
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194198/ https://www.ncbi.nlm.nih.gov/pubmed/12963694 http://dx.doi.org/10.1084/jem.20030361

Ejemplares similares

Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D
por: Davydova, Natalia, et al.
Publicado: (2016)

The VEGF signaling pathway in cancer: the road ahead
por: Stacker, Steven A., et al.
Publicado: (2013)

Emerging Roles for VEGF-D in Human Disease
por: Stacker, Steven A., et al.
Publicado: (2018)

Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1
por: Jha, Sawan Kumar, et al.
Publicado: (2017)

The connection between lymphangiogenic signalling and prostaglandin biology: A missing link in the metastatic pathway
por: Karnezis, Tara, et al.
Publicado: (2012)

Proteolytic Cleavages in the VEGF Family: Generating Diversity among Angiogenic VEGFs, Essential for the Activation of Lymphangiogenic VEGFs
por: Künnapuu, Jaana, et al.
Publicado: (2021)

VEGF‐D promotes pulmonary oedema in hyperoxic acute lung injury
por: Sato, Teruhiko, et al.
Publicado: (2016)

Alginate hydrogels allow for bioactive and sustained release of VEGF-C and VEGF-D for lymphangiogenic therapeutic applications
por: Campbell, Kevin T., et al.
Publicado: (2017)

CXCL7-Mediated Stimulation of Lymphangiogenic Factors VEGF-C, VEGF-D in Human Breast Cancer Cells
por: Yu, Minghuan, et al.
Publicado: (2010)

COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
por: Timoshenko, A V, et al.
Publicado: (2006)

Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication
por: Upile, Tahwinder, et al.
Publicado: (2009)

KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D
por: Jha, Sawan Kumar, et al.
Publicado: (2019)

Lymphangiogenic Gene Therapy With Minimal Blood Vascular Side Effects
por: Saaristo, Anne, et al.
Publicado: (2002)

Overexpression of VEGF in Testis and Epididymis Causes Infertility in Transgenic Mice: Evidence for Nonendothelial Targets for VEGF
por: Korpelainen, Eija I., et al.
Publicado: (1998)

Blockade of VEGF-C and VEGF-D modulates adipose tissue inflammation and improves metabolic parameters under high-fat diet
por: Karaman, Sinem, et al.
Publicado: (2014)

Hyperbaric Oxygen Inhibits Reperfusion-Induced Neutrophil Polarization and Adhesion Via Plasmin-Mediated VEGF Release
por: Francis, Ashish, et al.
Publicado: (2017)

VEGF-C is required for intestinal lymphatic vessel maintenance and lipid absorption
por: Nurmi, Harri, et al.
Publicado: (2015)

VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts
por: Nilsson, Ingrid, et al.
Publicado: (2010)

Elevated VEGF-D Modulates Tumor Inflammation and Reduces the Growth of Carcinogen-Induced Skin Tumors()
por: Honkanen, Hanne-Kaisa, et al.
Publicado: (2016)

Transgenic overexpression of VEGF-C induces weight gain and insulin resistance in mice
por: Karaman, Sinem, et al.
Publicado: (2016)

VEGF-C promotes the development of lymphatics in bone and bone loss
por: Hominick, Devon, et al.
Publicado: (2018)

Pro-lymphangiogenic VEGFR-3 signaling modulates memory T cell responses in allergic airway inflammation
por: Maisel, Katharina, et al.
Publicado: (2020)

VEGF-C-driven lymphatic drainage enables brain tumor immunosurveillance
por: Song, Eric, et al.
Publicado: (2020)

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
por: Gerhardt, Holger, et al.
Publicado: (2003)

Control of Gene Expression by Exosome-Derived Non-Coding RNAs in Cancer Angiogenesis and Lymphangiogenesis
por: Arcucci, Valeria, et al.
Publicado: (2021)

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)

Short and Long-Term Effects of hVEGF-A(165) in Cre-Activated Transgenic Mice
por: Leppänen, Pia, et al.
Publicado: (2006)

N-VEGF, the Autoregulatory Arm of VEGF-A
por: Katsman, Marina, et al.
Publicado: (2022)

KSHV Induction of Angiogenic and Lymphangiogenic Phenotypes
por: DiMaio, Terri A., et al.
Publicado: (2012)

VEGF(121)b and VEGF(165)b are weakly angiogenic isoforms of VEGF-A
por: Catena, Raúl, et al.
Publicado: (2010)

Targeting lymphatic vessel functions through tyrosine kinases
por: Williams, Steven P, et al.
Publicado: (2010)

The Presence of VEGF Receptors on the Luminal Surface of Endothelial Cells Affects VEGF Distribution and VEGF Signaling
por: Stefanini, Marianne O., et al.
Publicado: (2009)

Neuropilin-2 mediates VEGF-C–induced lymphatic sprouting together with VEGFR3
por: Xu, Yunling, et al.
Publicado: (2010)

Identification of Gene Expression Differences between Lymphangiogenic and Non-Lymphangiogenic Non-Small Cell Lung Cancer Cell Lines
por: Regan, Erin, et al.
Publicado: (2016)

VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart
por: Kivelä, Riikka, et al.
Publicado: (2014)

VEGF, VEGF165b and EG-VEGF expression is specifically related with hormone profile in pituitary adenomas
por: Corlan, Ana Silvia, et al.
Publicado: (2019)

Lymphangiogenic factors are associated with the severity of hypersensitivity pneumonitis
por: Yamashita, Masahiro, et al.
Publicado: (2015)

Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug
por: Stewart, Michael W
Publicado: (2012)

Phytochemicals Targeting VEGF and VEGF-Related Multifactors as Anticancer Therapy
por: Parveen, Amna, et al.
Publicado: (2019)

Binding of VEGF-A is sufficient to abrogate the disturbing effects of VEGF-B together with VEGF-A on retinal endothelial cells
por: Deissler, Heidrun L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_32bnlkmvp82e9mde7sksic6r96